This cohort study evaluates the association of coffee consumption with disease progression and death in patients with advanced or metastatic colorectal cancer.
This randomized clinical trial evaluates the efficacy and safety of nab-paclitaxel vs paclitaxel in patients with platinum-refractory metastatic urothelial cancer.
This cohort study uses data from the National Cancer Database to assess the association between adjuvant chemotherapy and survival in patients with node-negative early-stage non–small cell lung cancer (NSCLC) with vs without high-risk pathologic features.
This cross-sectional survey study examines whether Black and White men with prostate cancer differ in their willingness to discuss clinical trials with their physicians, and if so, whether patient-level barriers are associated with racial differences.
This prospective observational study assesses changes in treatment plans for patients with lung cancer and qualifies the types of changes observed as a direct result of the coronavirus disease 2019 pandemic.
This Viewpoint provides an evaluation of partial breast irradiation as an alternative to standard and hypofractionated whole-breast irradiation in terms of its ability to reduce duration of treatment and provide equivalent outcomes, comparable or reduced adverse effects, and cost-effectiveness
This cohort study uses data from an existing cohort of patients undergoing resection of pancreatic cancer to assess the overall survival of patients treated with neoadjuvant FOLFIRINOX after surgery for pancreatic ductal adenocarcinoma.
This nonrandomized clinical trial evaluates the use of doxorubicin and pembrolizumab in patients with metastatic/unresectable anthracycline-naive sarcoma.
A 48-year-old man with a history of rectal adenocarcinoma and multiple lung metastases presents with a 1-cm posterior subglottic lesion of unclear origin found on restaging scans. What is your diagnosis?
This Viewpoint explores whether hospital death rates should still be considered an appropriate quality metric when it comes to the care of patients with cancer.
This phase 3, randomized, controlled, partially blinded interventional study evaluates the antitumor activity of pembrolizumab, pembrolizumab plus chemotherapy, or chemotherapy alone in patients with untreated, advanced gastric/gastroesophageal junction cancer with PD-L1 combined positive score ≥1.
This phase 2 randomized clinical trial compares the efficacy of eribulin plus pembrolizumab vs eribulin alone in hormone receptor–positive, ERBB2-negative metastatic breast cancer.
This cross-sectional study applies natural language processing to electronic health records from a large health care delivery system to examine performance status documentation among patients newly diagnosed with colorectal cancer.
This Viewpoint discusses how the COVID-19 pandemic may reshape clinical practice and clinical research as new technologies are incorporated and old practices are revisited and revamped.
Create a personal account or sign in to: